TITLE

Urgent Intracranial Angioplasty after Combined Systemic and Intra-Arterial Thrombolysis in Acute Stroke

AUTHOR(S)
Sadikin, Cindy; Iskandar, Agustinus; Pratanu, Iswanto; Yudi, Hartono
PUB. DATE
November 2008
SOURCE
Interventional Neuroradiology;2008, Vol. 14 Issue Supp2, p91
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
We report a case of a 59-year-old man who presented with an acute stroke involving the territory of his left middle cerebral artery, and who was treated with combined systemic and intraarterial thrombolysis. After these treatments, the segment remained stenotic. An urgent intracranial angioplasty was performed, resulting in satisfactory recanalization of the stenotic segment, and significant improvement of his National Institutes of Health Stroke Scale (NIHSS) from 14 to 5. This case report suggests an effective alternate protocol for treatment of acute stroke with arterial occlusion: immediate smaller dose of IV tissue plasminogen activator (tPA), followed by angiogram, intra-arterial thrombolysis, and angioplasty if indicated.
ACCESSION #
37836013

 

Related Articles

  • The risk of thrombolysis in 'stroke mimics': a case report. Kna├»ssi, Nesrine; Derex, Laurent; Cho, Tae-Hee; Marnet, Dominique; Nighoghossian, Norbert // Neurological Sciences;Oct2011, Vol. 32 Issue 5, p973 

    No abstract available.

  • THROMBOLYTIC THERAPY FOR ACTUE ISCHEMIC STROKE. Hawn, Ann M.; Baldwin, Laura-Mae // Journal of Family Practice;Dec1997, Vol. 45 Issue 6, p470 

    This article presents a study that investigated the impact of thrombolytic therapy on the outcome of acute ischemic stroke. Randomized controlled trials of thrombolysis in acute ischemic stroke have produced variable results. Nonetheless, on the basis of the National Institute of Neurological...

  • Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. Koudstaal, P.J.; Stibbe, J.; Vermeulen, M. // BMJ: British Medical Journal (International Edition);12/17/88, Vol. 297 Issue 6663, p1571 

    Investigates the occurrence of fatal ischemic brain edema after early thrombolysis with tissue plasminogen activator in acute stroke. Administration of a computed tomography scan; Symptoms of the disease; Causes of ischemic stroke.

  • Cardioembolic stroke on unaffected side during thrombolysis for acute ischemic stroke. Garg, Arun; Yaduvanshi, Amitabh; Mohindra, Kapil Dev // Neurology India;Jan2010, Vol. 58 Issue 1, p112 

    Cardiac thrombus is not an established contraindication to thrombolysis with intravenous tissue plasminogen activator in acute ischemic stroke. Recurrent ischemic stroke involving an initially unaffected arterial territory during the course of thrombolysis in stroke has been reported, but...

  • TERAPEUTICAS INTERVENCIONISTAS PARA EL ACCIDENTE CEREBROVASCULAR ISQUEMICO. Rabadan, Alejandra T.; Sposato, Luciano; Mazia, Claudio // Medicina (Buenos Aires);2010, Vol. 70 Issue 5, p463 

    New options have been developed for the prevention and treatment of acute ischemic stroke in the last 20 years, such as carotid endarterectomy and intravenous thrombolysis with tissue plasminogen activator. Scientific evidence has supported their use in developed countries, while there is an...

  • Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: An unknown danger. Adatia, Sweta; Sanghani, Sejal; Sanzgiri, Prakash; Chauhan, Vinay; Hastak, Shirish // Annals of Indian Academy of Neurology;Jan-Mar2010, Vol. 13 Issue 1, p64 

    Thrombolysis with intravenous tissue (IV) plasminogen activator (tPA) is considered for patients with acute ischemic stroke falling within the described inclusion criteria defined by The National Institute of Neurological Disorders and Stroke (NINDS) rtPA trial. Complications of IV thrombolysis...

  • Stroke treatment in the ED: Are your practices up to par?  // RN;Jul2000, Vol. 63 Issue 7, p24hf2 

    Provides instructions on providing thrombolytic therapy to patients who need it. Treatment of stroke patients with tissue plasminogen activator (t-PA), the only clot-busting medication approved by the United States Food and Drug Administration; Need for the adoption of t-PA by emergency...

  • Utilization and outcome of thrombolytic therapy for acute stroke in Pakistan. Wasay, Mohammad; Barohi, Hazim; Malik, Abdul; Yousuf, Adnan; Awan, Safia; Kamal, Ayeesha K. // Neurological Sciences;Apr2010, Vol. 31 Issue 2, p223 

    Our objective was to identify the outcome of patients treated with tissue plasminogen activator (r-tPa) in Pakistan and compare these data to available regional and international data. The charts of all patients treated with r-tPa for acute stroke at two centers in Pakistan (Aga Khan University,...

  • Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. Haihao Zhu; Xiang Fan; Zhanyang Yu; Jianxiang Liu; Murata, Yoshihiro; Jie Lu; Song Zhao; Hajjar, Katherine A.; Lo, Eng H.; Xiaoying Wang // Journal of Cerebral Blood Flow & Metabolism;Jun2010, Vol. 30 Issue 6, p1137 

    Recent studies showed that soluble annexin A2 dramatically increases tissue plasminogen activator (tPA)-mediated plasmin generation in vitro, and reduces thrombus formation in vivo. Here, we hypothesize that combining annexin A2 with tPA can significantly enhance thrombolysis efficacy, so that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics